NovaQuest Capital Management
Finance · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4208 Six Forks Rd Ste 920, Raleigh, Nort...Phone Number
(919) 459-8620Website
www.novaquest.comRevenue
$14.4 MillionIndustry
About NovaQuest Capital Management
NovaQuest Capital Management Org Chart
Is NovaQuest Capital Management your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if NovaQuest Capital Management has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if NovaQuest Capital Management is spiking on competitors!
Funding: Get notified immidiatlly once NovaQuest Capital Management has new funding data
Congratulate Masked Content for being promoted to Masked Content at NovaQuest Capital Management
NovaQuest Capital Management, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on NovaQuest Capital Management recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if NovaQuest Capital Management had a recent Job posting/layoffs
Product Launch: Get notified when NovaQuest Capital Management launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to NovaQuest Capital Management
Compare insights from companies similar to NovaQuest Capital Management, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NovaQuest Capital Managem...
Company Profile Activity
Activity Insights
NovaQuest Capital Management is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
NovaQuest Capital Management is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about NovaQuest Capital Management.
NovaQuest Capital Management financials insights
Gather financial insights about NovaQuest Capital Management, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Private Equity
$59.9M
NovaQuest Capital Management Tech Stack
A closer look at the technologies used by NovaQuest Capital Management
Most Recent Scoops
NovaQuest Capital Management News & Media
Mycovia Pharmaceuticals, Inc. Announces AllianceRx Walgreens Pharmacy and Walgreens Community-based Specialty Pharmacies as Exclusive Distributor of VIVJOA®
- VIVJOA is available through Walgreens specialty pharmacies - Patients with chronic yeast infections benefit from holistic patient care through Walgreens specialty pharmacies DURHAM, N.C., March 26, 2024 /PRNewswire/ -- Mycovia Pharmaceuticals, Inc. ("Mycovia"), an emerging...Mycovia Pharmaceuticals, Inc. Announces Partner Jiangsu Hengrui Pharmaceuticals Co., Ltd's Commercial Launch of VIVJOA® (Oteseconazole) Capsules for the Treatment of Severe Vulvovaginal Candidiasis (VVC) in China
- VIVJOA is now a new option for treating severe VVC in China - A 2-Day Oral Course of VIVJOA provides significantly better cure rates than fluconazole in severe VVC DURHAM, N.C., Feb. 7, 2024 /PRNewswire/ -- Mycovia Pharmaceuticals, Inc. ("Mycovia"), an emerging biopharmaceutical...Mycovia Pharmaceuticals, Inc. Announces Partner Jiangsu Hengrui Pharmaceuticals Co., Ltd's Approval of Oteseconazole Capsules for the Treatment of Severe Vulvovaginal Candidiasis (VVC) in China
- Oteseconazole Capsules were statistically superior to fluconazole, the current standard-of-care, in treating women with severe VVC - Oteseconazole Capsules were found to be safe and more effective than fluconazole - China commercial launch of Oteseconazole Capsules expected in late 2023...FibroGen Announces $50 Million Royalty Monetization Financing with NovaQuest Capital Management
SAN FRANCISCO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced a royalty monetization financing with NovaQuest Capital Management (NovaQuest) that will result in proceeds to FibroGen in the amount of $50 million, bringing non-dilutive capital to drive innovation and growth.
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NovaQuest Capital Management
Founded by a team of accomplished industry professionals who began working together in 2000, NovaQuest Capital Management is a premier biopharma and life sciences investment firm. NovaQuest pioneered a PRODUCT FINANCE investment solution for the industry, providing at-risk, nondilutive funding that enables partner companies to advance pivotal clini... Read More